Advances in our understanding of genetic markers and targeted therapies for pediatric LCH
Sign Up to like & getrecommendations! Published in 2024 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2024.2353772
Abstract: ABSTRACT Introduction Langerhans cell histiocytosis (LCH) is a rare myeloid neoplasm, encompassing a diverse clinical spectrum ranging from localized bone or skin lesions to a multisystemic life-threatening condition. Over the past decade, there has been… read more here.
Keywords: targeted therapies; genetic markers; lch; pediatric lch ... See more keywords